GLP-1 drugs in PCOS
GLP-1 based medicines in polycystic ovary syndrome.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 1, 5, 7, 7, 5.
New guidelines and consensus this year
- [Guidelines for the diagnosis and treatment of obstructive sleep apnea in adults (2025)]Zhonghua Jie He He Hu Xi Za Zhi2026 Mar 12
All papers from the last 12 months
92 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Eicosatrienoic acid improves PCOS in mice by modulating the intestinal barrier and ovarian inflammationJ Nutr Biochem2026 DecPMID 42526542
- Preconception incretin therapy reduces pregnancy and cardiometabolic outcomes in polycystic ovary syndromeJ Clin Endocrinol Metab2026 Oct 10PMID 42857939
- Neuroendocrine regulation of adipose partitioning in polyendocrine metabolic ovarian syndrome: the gut-brain-adipose axisJ Endocrinol Invest2026 Oct 9PMID 42853507Review
- Beyond body mass index: A contemporary review of obesity and female infertilityClin Exp Reprod Med2026 Oct 8PMID 42844892
- Nutrition Care and Dietetic Practice in Managing Metabolic and Endocrine Dysfunction in Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications and Opportunities in the Context of the Name Change of Polycystic Ovarian Syndrome to PMOSAdv Nutr2026 OctPMID 42749129Review
- Comment on "effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity: A pilot prospective study"Clin Nutr ESPEN2026 OctPMID 42674357
- Reply - Letter to the editor: Comment on "effect of semaglutide with metformin for weight loss and fertility in polycystic ovary syndrome (PCOS) patients with obesity: A pilot prospective studyClin Nutr ESPEN2026 OctPMID 42674355
- The neuroendocrine-appetite-mental health triangle in PMOS: Implications for GLP-1 receptor agonist therapyNeurosci Biobehav Rev2026 OctPMID 42419462Review
- What obgyns need to know about GLP-1 receptor agonistsCurr Opin Obstet Gynecol2026 Oct 1PMID 42108205Review
- Polycystic ovary syndrome: An insight into pathophysiology, current management, and emerging therapeutic approachesCurr Opin Pharmacol2026 Sep 25PMID 42880183Review
More obstetrics & gynecology trends
All specialties →Non-invasive diagnosis of endometriosis
Biomarkers and imaging to diagnose endometriosis without surgery.
Key point: Experienced dynamic ultrasound has high specificity and generally high sensitivity for ovarian endometriomas and many deep lesions, with variable sensitivity for parametrial/superficial disease.
Postpartum haemorrhage
Prevention, early detection and treatment of bleeding after birth.
Cell-free DNA prenatal screening
Screening for fetal conditions from cell-free DNA in maternal blood.
Remote blood pressure monitoring in pregnancy
Home and remote blood pressure monitoring during pregnancy and after birth.
Key point: Remote blood pressure monitoring reduced antenatal outpatient appointments and likelihood of inpatient admissions without increasing adverse fetal and maternal outcomes.
Induction of labour at 39 weeks
Elective induction at 39 weeks in low-risk pregnancies.
Uterus transplantation
Uterus transplantation for absolute uterine factor infertility.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
("polycystic ovary syndrome"[tiab] OR PCOS[tiab]) AND ("GLP-1"[tiab] OR semaglutide[tiab] OR liraglutide[tiab] OR tirzepatide[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.